⏳ Fetching live dividend data...
Home › Calculator › RTNXF Dividend Calculator 2026
Renalytix Plc · OTC
Price: $0.08 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RTNXF → $1411670956533.76M in 10 years · $113,114,659,978,666,690.00/month
Renalytix Plc specializes in developing artificial intelligence-driven in vitro diagnostic solutions for kidney diseases. Its flagship offering, KidneyIntelX, is a sophisticated diagnostic platform. This system leverages an AI-powered algorithm that integrates diverse data inputs, including validated blood-based biomarkers, an individual's inherited genetics, and personalized patient data extracted from electronic health records, to generate a unique risk score for each patient. These innovations serve several critical applications, such as diagnosing and forecasting the progression of kidney disease, guiding clinical patient management, aiding in patient selection for pharmaceutical trials, and discovering novel drug targets. The company has forged strategic alliances, including licensing agreements with prominent institutions. It collaborates with Mount Sinai Health System for the development and commercialization of AI-driven diagnostic tools for renal conditions. Another agreement is with Joslin Diabetes Center, Inc., focusing on developing and marketing products for kidney disease diagnosis and prediction using biomarkers. Additionally, a partnership with Kantaro Biosciences LLC is dedicated to creating and commercializing laboratory tests for detecting SARS-CoV-2 antibodies. Furthermore, Renalytix has formed a significant collaboration with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine. This alliance aims to implement an advanced clinical care model designed to bolster kidney health and mitigate the advancement of kidney disease and renal failure among at-risk populations. Incorporated in 2018, Renalytix Plc is headquartered in New York, New York. The company adopted its current name in June 2021, having previously operated as Renalytix AI plc.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RTNXF position with:
Real after-tax yield depends on where you live and how you hold RTNXF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2125.00% | 2122.20% | $212,500 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2000.00% | 1997.20% | $200,000 / yr |
| 🇬🇧 UK ISA | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2281.25% | 2278.45% | $228,125 / yr |
| 🇨🇦 TFSA | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇨🇦 CA Taxable | 25% | 1875.00% | 1872.20% | $187,500 / yr |
| 🇦🇺 Super (pension) | 15% | 2125.00% | 2122.20% | $212,500 / yr |
| 🇦🇺 AU Taxable | 30% | 1750.00% | 1747.20% | $175,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1840.63% | 1837.83% | $184,063 / yr |
| 🇫🇷 FR Taxable | 30% | 1750.00% | 1747.20% | $175,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
RTNXF pays quarterly — 4 times per year. Next ex-div: TBD.
How RTNXF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RTNXF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RTNXF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Renalytix Plc (RTNXF) is currently trading at $0.08, trading near its 52-week low. The current dividend yield is 2500.00% based on an annual payout of $2.00 per share.
Renalytix Plc (RTNXF) is a healthcare stock currently trading at $0.08 with a dividend yield of 2500.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever